Does anybody have any experiences with Sulodexide (Aterina) to address endothelial dysfunction, it’s sort of an oral version of heparin? (Of course this isn’t a cure, but possibly a drug to add on top of the usual stack).
I've heard from his patients that Dr. Laubscher, who's the clinical partner of Resia Pretorius, usually prescribes it to patients that don't respond well enough to TT, whatever that may mean.
It hasn’t received much attention in research apart from the quite significant Tunisian study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710949/, https://pubmed.ncbi.nlm.nih.gov/356...in.org/articles/10.3389/fcvm.2021.745758/full (they weren’t published in the most prolific journals, but there seems to be a bias towards African medicine, respectively this is quite common in science in Tunisia I have been told). The study is a year old, with the theory being even older, but the authors haven’t released any more work into this direction. I also can’t find information on the TUN-EndCOV study. After the studies were released, there was a short hype, but then it sort of disappeared from the radar. Did some patients try it without success?
I've heard from his patients that Dr. Laubscher, who's the clinical partner of Resia Pretorius, usually prescribes it to patients that don't respond well enough to TT, whatever that may mean.
It hasn’t received much attention in research apart from the quite significant Tunisian study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710949/, https://pubmed.ncbi.nlm.nih.gov/356...in.org/articles/10.3389/fcvm.2021.745758/full (they weren’t published in the most prolific journals, but there seems to be a bias towards African medicine, respectively this is quite common in science in Tunisia I have been told). The study is a year old, with the theory being even older, but the authors haven’t released any more work into this direction. I also can’t find information on the TUN-EndCOV study. After the studies were released, there was a short hype, but then it sort of disappeared from the radar. Did some patients try it without success?